TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

MEROPENEM
Infectious Disease Approved 2015-04-30
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
10
Years on Market

Details

Status
Prescription
First Approved
2015-04-30
Routes
INTRAVENOUS
Dosage Forms
POWDER

Companies

B BRAUN MEDICAL
Active Ingredient: MEROPENEM

MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Approval History

Loading approval history...

What MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Treats

3 indications

MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is approved for 3 conditions since its original approval in 2015. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Skin and Skin Structure Infections
  • Intra-abdominal Infections
  • Bacterial Meningitis
Source: FDA Label

Drugs Similar to MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMPICILLIN AND SULBACTAM
AMPICILLIN SODIUM
2 shared
EUGIA PHARMA SPECLTS
Shared indications:
Skin and Skin Structure InfectionsIntra-Abdominal Infections
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
B BRAUN
Shared indications:
Skin and Skin Structure InfectionsIntra-Abdominal Infections
ERTAPENEM SODIUM
ERTAPENEM SODIUM
2 shared
ACS DOBFAR SPA
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure Infections
INVANZ
ERTAPENEM SODIUM
2 shared
Merck
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure Infections
PIPERACILLIN
PIPERACILLIN SODIUM
2 shared
ISTITUTO BIO ITA SPA
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
2 shared
B BRAUN MEDICAL
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
TIGECYCLINE
TIGECYCLINE
2 shared
Fresenius Kabi
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
TYGACIL
TIGECYCLINE
2 shared
PF PRISM CV
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
ZOSYN IN PLASTIC CONTAINER
PIPERACILLIN SODIUM
2 shared
Baxter
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
AMPICILLIN SODIUM
AMPICILLIN SODIUM
1 shared
SAGENT PHARMS INC
Shared indications:
Bacterial Meningitis
AVELOX
MOXIFLOXACIN HYDROCHLORIDE
1 shared
Bayer
Shared indications:
Skin and Skin Structure Infections
CEFAZOLIN AND DEXTROSE
CEFAZOLIN SODIUM
1 shared
B BRAUN
Shared indications:
Skin and Skin Structure Infections
CEFAZOLIN IN DEXTROSE
CEFAZOLIN SODIUM
1 shared
Baxter
Shared indications:
Skin and Skin Structure Infections
CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
1 shared
QILU ANTIBIOTICS
Shared indications:
Skin and Skin Structure Infections
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
1 shared
SAMSON MEDCL
Shared indications:
Skin and Skin Structure Infections
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
1 shared
Baxter
Shared indications:
Skin and Skin Structure Infections
CIPROFLOXACIN HYDROCHLORIDE
CIPROFLOXACIN HYDROCHLORIDE
1 shared
UNIQUE
Shared indications:
Skin and Skin Structure Infections
CLARITHROMYCIN
CLARITHROMYCIN
1 shared
Teva
Shared indications:
Skin and Skin Structure Infections
CLEOCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
1 shared
Pfizer
Shared indications:
Skin and Skin Structure Infections
DAPTOMYCIN
DAPTOMYCIN
1 shared
ASPIRO
Shared indications:
Skin and Skin Structure Infections
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

ClinicalTrials.gov โ†— Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Meropenem for Injection, USP is a penem antibacterial indicated for the treatment of: Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). Complicated intra-abdominal infections (adult and pediatric patients). Bacterial meningitis (pediatric patients 3 months of age and older only). To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection, USP and other antibacterial drugs, Meropenem for Injection, USP should only be used to treat or prevent infections that are proven or stro...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA202106 โ†’ Label: DailyMed โ†’ Patents: FDA Orange Book โ†’ Trials: ClinicalTrials.gov โ†’

Data sourced from official FDA and NIH databases. Click links to verify on original sources.